Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-62.14
↓ 79% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-34.68
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -62.14 | -221.2% |
| 2024 | -19.34 | -536.3% |
| 2023 | -3.04 | +41.3% |
| 2022 | -5.18 | +76.2% |
| 2021 | -21.77 | +14.0% |
| 2020 | -25.32 | +66.4% |
| 2019 | -75.46 | -15.8% |
| 2018 | -65.18 | - |